NCT00980707View on ClinicalTrials.gov

Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

November 30, 2010

Conditions
Allergic Asthma
Interventions
DRUG

Inhaled corticosteroid (fluticasone)

inhaled fluticasone 220 ug/bid

Trial Locations (1)

98105

Associated Scientists to Help Minimize Allergies, Seattle

Sponsors
All Listed Sponsors
collaborator

Benaroya Research Institute

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Associated Scientists to Help Minimize Allergies

OTHER

NCT00980707 - Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma | Biotech Hunter | Biotech Hunter